Case Report
Copyright ©The Author(s) 2016.
World J Clinical Cases. Sep 16, 2016; 4(9): 258-263
Published online Sep 16, 2016. doi: 10.12998/wjcc.v4.i9.258
Figure 2
Figure 2 Case 2. A: Before treatment, showing multiple separate and confluent pathological foci of fluorine-18 fluorodeoxyglucose uptake in local dense areas of subcutaneous fat (the largest are indicated by arrows on the whole-body image); B: After 7 cycles of the GEM-P chemotherapy regimen, showing preservation of metabolically inactive areas of consolidation of subcutaneous fat. GEM-P: Gemcitabine, cisplatin and methylprednisolone.